Member access

4-Traders Homepage  >  Shares  >  Nyse  >  MEDNAX Inc    MD   US58502B1061

MEDNAX INC (MD)

5
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales1 5881 8172 1542 4242 6722 937
Operating income (EBITDA)381420492555602658
Operating profit (EBIT)355390452510552607
Pre-Tax Profit (EBT)-388448---
Net income218241281315339370
EPS ( $)2,242,432,783,153,483,88
Dividend per Share ( $)------
Yield------
Announcement Date02/02/2012
11:00am
01/31/2013
11:00am
01/30/2014
11:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt6,74116--34,2-
Finance--10,410,5-79,1
Operating income (EBITDA)381420492555602658
Leverage
(Debt/EBITDA)
0,02x0,28x--0,06x-
Capital Expenditure31,314,515,618,022,126,1
Book Value Per Share (BVPS)17,7 $20,3 $23,2 $25,0 $27,7 $32,5 $
Cash Flow per Share2,78 $3,28 $4,02 $3,82 $4,42 $5,03 $
Announcement Date02/02/2012
11:00am
01/31/2013
11:00am
01/30/2014
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 6 719 M$ -
Entreprise Value (EV) 6 708 M$ 6 753 M$
Valuation 2014e 2015e
PER (Price / EPS) 21,3x 19,3x
Capitalization / Revenue 2,77x 2,51x
EV / Revenue 2,77x 2,53x
EV / EBITDA 12,1x 11,2x
Yield (DPS / Price) - -
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 21,0% 20,7%
operating Leverage (Delta EBIT / Delta Sales) 1,02x 0,81x
Net Margin (Net Profit / Revenue) 13,0% 12,7%
ROA (Net Profit / Asset) 9,50% 9,23%
ROE (Net Profit / Equities) 12,9% 12,5%
Rate of Dividend - -
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   0,74% 0,83%
Cash Flow / Sales (Taux d'autofinancement) 15,8% 16,6%
Capital Intensity (Assets / Sales) 1,37x 1,37x
Financial Leverage (Net Debt / EBITDA) -0,02x 0,06x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF